Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127380171 | 12738017 | 1 | I | 20160829 | 20160912 | 20160912 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-071883 | BRISTOL MYERS SQUIBB | 0.00 | M | Y | 79.40000 | KG | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127380171 | 12738017 | 1 | PS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | UNK | 19898 | TABLET | |||||||||
127380171 | 12738017 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 0 | 10 | MG | TABLET | BID | ||||||
127380171 | 12738017 | 3 | SS | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 4 MG, TID | 0 | 4 | MG | TABLET | TID | ||||||
127380171 | 12738017 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG, UNK | U | 0 | 81 | MG | |||||||
127380171 | 12738017 | 5 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
127380171 | 12738017 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 5 MG, UNK | U | 0 | 5 | MG | |||||||
127380171 | 12738017 | 7 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Unknown | 25 MG, UNK | U | 0 | 25 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127380171 | 12738017 | 1 | Blood cholesterol increased |
127380171 | 12738017 | 2 | Gait disturbance |
127380171 | 12738017 | 3 | Muscle spasms |
127380171 | 12738017 | 4 | Product used for unknown indication |
127380171 | 12738017 | 5 | Product used for unknown indication |
127380171 | 12738017 | 6 | Product used for unknown indication |
127380171 | 12738017 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127380171 | 12738017 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127380171 | 12738017 | Paraesthesia | |
127380171 | 12738017 | Rhabdomyolysis | |
127380171 | 12738017 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127380171 | 12738017 | 2 | 20160706 | 0 | ||
127380171 | 12738017 | 6 | 201307 | 0 | ||
127380171 | 12738017 | 7 | 201307 | 0 |